{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:59:49Z","timestamp":1758329989130,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.yjmcc.2020.07.005","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T21:27:58Z","timestamp":1595021278000},"page":"41-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Using \u201cold\u201d medications to fight new COVID-19: Re-purposing with a purpose"],"prefix":"10.1016","volume":"146","author":[{"given":"Yibin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Foo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Thum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2020.07.005_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2020.04.031","article-title":"SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: from basic science to clinical implications","volume":"144","author":"Gro\u00df","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2020.04.010","article-title":"Cardiovascular molecular mechanisms of disease with COVID-19","volume":"141","author":"Foo","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"25","key":"10.1016\/j.yjmcc.2020.07.005_bb0015","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of Hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0025","series-title":"N Engl J Med","article-title":"Remdesivir for the treatment of Covid-19 - preliminary report","author":"Beigel","year":"2020"},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Preliminary Report ACTT-1 Study Group Members","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvaa056","article-title":"Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality","author":"Cannata","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.yjmcc.2020.07.005_bb0050","article-title":"The association between angiotensin-converting enzyme inhibitors and angiotensin receptor Blockers and the number of Covid-19 confirmed cases and deaths in the United States: geospatial study","author":"Johnson","year":"2020","journal-title":"medRxiv"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:30:38Z","timestamp":1758313838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820302273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":10,"alternative-id":["S0022282820302273"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.07.005","relation":{},"ISSN":["0022-2828"],"issn-type":[{"type":"print","value":"0022-2828"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using \u201cold\u201d medications to fight new COVID-19: Re-purposing with a purpose","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}